Involvement of the endocannabinoid system in attentional modulation of nociceptive behaviour in rats

European Journal of Pain (United Kingdom)

Volumn 19, Issue 8, 2015, Pages 1177-1185

  Ford, G K ^a   Moriarty, O ^a   Okine, B N ^a   Tully, E ^a   Mulcahy, A ^a   Harhen, B ^a   Finn, D P ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; ENDOCANNABINOID; FORMALDEHYDE; RIMONABANT; 2-ARACHIDONYLGLYCEROL; ACYLGLYCEROL; AMIDE; ARACHIDONIC ACID DERIVATIVE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; ATTENTION; CONTROLLED STUDY; DISTRACTIBILITY; LIQUID CHROMATOGRAPHY; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; TANDEM MASS SPECTROMETRY; VENTRAL HIPPOCAMPUS; AGONISTS; ANIMAL; ANIMAL BEHAVIOR; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DRUG EFFECTS; EXPLORATORY BEHAVIOR; FEAR; HIPPOCAMPUS; METABOLISM; PAIN; PAIN MEASUREMENT; PATHOPHYSIOLOGY; PSYCHOLOGY;

ANIMALS; ARACHIDONIC ACIDS; ATTENTION; BEHAVIOR, ANIMAL; CANNABINOID RECEPTOR ANTAGONISTS; ENDOCANNABINOIDS; EXPLORATORY BEHAVIOR; FEAR; GLYCERIDES; HIPPOCAMPUS; MALE; NOCICEPTION; PAIN; PAIN MEASUREMENT; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PYRAZOLES; RATS; RECEPTOR, CANNABINOID, CB1;

EID: 84939771792     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1002/ejp.646     Document Type: Article

References (52)

1. Abela, A.R., Dougherty, S.D., Fagen, E.D., Hill, C.J., Chudasama, Y., (2013). Inhibitory control deficits in rats with ventral hippocampal lesions. Cerebral Cortex 23, 1396-1409.
2. Apkarian, A.V., Bushnell, M.C., Treede, R.D., Zubieta, J.K., (2005). Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain 9, 463-484.
3. Arguello, P.A., Jentsch, J.D., (2004). Cannabinoid CB1 receptor-mediated impairment of visuospatial attention in the rat. Psychopharmacology (Berl) 177, 141-150.
4. Azmitia, E.C., Segal, M., (1978). An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol 179, 641-667.
5. Bantick, S.J., Wise, R.G., Ploghaus, A., Clare, S., Smith, S.M., Tracey, I., (2002). Imaging how attention modulates pain in humans using functional MRI. Brain 125, 310-319.
6. Beaulieu, P., Bisogno, T., Punwar, S., Farquhar-Smith, W.P., Ambrosino, G., Di Marzo, V., Rice, A.S., (2000). Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat. Eur J Pharmacol 396, 85-92.
7. Benedetti, F., Amanzio, M., Rosato, R., Blanchard, C., (2011). Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors. Nat Med 17, 1228-1230.
8. Blasco-Ibanez, J.M., Martinez-Guijarro, F.J., Freund, T.F., (1998). Enkephalin-containing interneurons are specialized to innervate other interneurons in the hippocampal CA1 region of the rat and guinea-pig. Eur J Neurosci 10, 1784-1795.
9. Bushnell, M.C., Ceko, M., Low, L.A., (2013). Cognitive and emotional control of pain and its disruption in chronic pain. Nat Rev Neurosci 14, 502-511.
10. Butler, R.K., Finn, D.P., (2009). Stress-induced analgesia. Prog Neurobiol 88, 184-202.
11. Calignano, A., La Rana, G., Giuffrida, A., Piomelli, D., (1998). Control of pain initiation by endogenous cannabinoids. Nature 394, 277-281.
12. Costa, B., Trovato, A.E., Colleoni, M., Giagnoni, G., Zarini, E., Croci, T., (2005). Effect of the cannabinoid CB1 receptor antagonist, SR141716, on nociceptive response and nerve demyelination in rodents with chronic constriction injury of the sciatic nerve. Pain 116, 52-61.
13. Di Marzo, V., (2008). Targeting the endocannabinoid system: To enhance or reduce? Nat Rev Drug Discov 7, 438-455.
14. Eccleston, C., Crombez, G., (1999). Pain demands attention: A cognitive-affective model of the interruptive function of pain. Psychol Bull 125, 356-366.
15. Favaroni Mendes, L.A., Menescal-de-Oliveira, L., (2008). Role of cholinergic, opioidergic and GABAergic neurotransmission of the dorsal hippocampus in the modulation of nociception in guinea pigs. Life Sci 83, 644-650.
16. Felder, C.C., Nielsen, A., Briley, E.M., Palkovits, M., Priller, J., Axelrod, J., Nguyen, D.N., Richardson, J.M., Riggin, R.M., Koppel, G.A., Paul, S.M., Becker, G.W., (1996). Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett 393, 231-235.
17. Finn, D.P., Beckett, S.R., Richardson, D., Kendall, D.A., Marsden, C.A., Chapman, V., (2004). Evidence for differential modulation of conditioned aversion and fear-conditioned analgesia by CB1 receptors. Eur J Neurosci 20, 848-852.
18. Floyd, N.S., Price, J.L., Ferry, A.T., Keay, K.A., Bandler, R., (2000). Orbitomedial prefrontal cortical projections to distinct longitudinal columns of the periaqueductal gray in the rat. J Comp Neurol 422, 556-578.
19. Ford, G.K., Finn, D.P., (2008). Clinical correlates of stress-induced analgesia: Evidence from pharmacological studies. Pain 140, 3-7.
20. Ford, G.K., Kieran, S., Dolan, K., Harhen, B., Finn, D.P., (2011). A role for the ventral hippocampal endocannabinoid system in fear-conditioned analgesia and fear responding in the presence of nociceptive tone in rats. Pain 152, 2495-2504.
21. Ford, G.K., Moriarty, O., McGuire, B.E., Finn, D.P., (2008). Investigating the effects of distracting stimuli on nociceptive behaviour and associated alterations in brain monoamines in rats. Eur J Pain 12, 970-979.
22. Freund, T.F., Katona, I., Piomelli, D., (2003). Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83, 1017-1066.
23. Gasbarri, A., Packard, M.G., Campana, E., Pacitti, C., (1994). Anterograde and retrograde tracing of projections from the ventral tegmental area to the hippocampal formation in the rat. Brain Res Bull 33, 445-452.
24. Hoffman, H.G., Patterson, D.R., Carrougher, G.J., (2000). Use of virtual reality for adjunctive treatment of adult burn pain during physical therapy: A controlled study. Clin J Pain 16, 244-250.
25. Holland, P.C., Han, J.S., Gallagher, M., (2000). Lesions of the amygdala central nucleus alter performance on a selective attention task. J Neurosci 20, 6701-6706.
26. Ishikawa, A., Nakamura, S., (2006). Ventral hippocampal neurons project axons simultaneously to the medial prefrontal cortex and amygdala in the rat. J Neurophysiol 96, 2134-2138.
27. Lafenetre, P., Chaouloff, F., Marsicano, G., (2009). Bidirectional regulation of novelty-induced behavioral inhibition by the endocannabinoid system. Neuropharmacology 57, 715-721.
28. Maclaren, J.E., Cohen, L.L., (2007). Interventions for paediatric procedure-related pain in primary care. Paediatr Child Health 12, 111-116.
29. Olango, W.M., Roche, M., Ford, G.K., Harhen, B., Finn, D.P., (2012). The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear-conditioned analgesia and controls fear expression in the presence of nociceptive tone. Br J Pharmacol 165, 2549-2560.
30. Panlilio, L.V., Mazzola, C., Medalie, J., Hahn, B., Justinova, Z., Drago, F., Cadet, J.L., Yasar, S., Goldberg, S.R., (2009). Anandamide-induced behavioral disruption through a vanilloid-dependent mechanism in rats. Psychopharmacology (Berl) 203, 529-538.
31. Pattij, T., Janssen, M.C., Schepers, I., Gonzalez-Cuevas, G., de Vries, T.J., Schoffelmeer, A.N., (2007). Effects of the cannabinoid CB1 receptor antagonist rimonabant on distinct measures of impulsive behavior in rats. Psychopharmacology (Berl) 193, 85-96.
32. Paxinos, G., Watson, C., (1998). The Rat Brain in Stereotaxic Coordinates (New York: Academic Press).
33. Petrovic, P., Ingvar, M., (2002). Imaging cognitive modulation of pain processing. Pain 95, 1-5.
34. Petrovic, P., Petersson, K.M., Ghatan, P.H., Stone-Elander, S., Ingvar, M., (2000). Pain-related cerebral activation is altered by a distracting cognitive task. Pain 85, 19-30.
35. Pikkarainen, M., Ronkko, S., Savander, V., Insausti, R., Pitkanen, A., (1999). Projections from the lateral, basal, and accessory basal nuclei of the amygdala to the hippocampal formation in rat. J Comp Neurol 403, 229-260.
36. Pitkanen, A., Pikkarainen, M., Nurminen, N., Ylinen, A., (2000). Reciprocal connections between the amygdala and the hippocampal formation, perirhinal cortex, and postrhinal cortex in rat. A review. Ann NY Acad Sci 911, 369-391.
37. Ploghaus, A., Narain, C., Beckmann, C.F., Clare, S., Bantick, S., Wise, R., Matthews, P.M., Rawlins, J.N., Tracey, I., (2001). Exacerbation of pain by anxiety is associated with activity in a hippocampal network. J Neurosci 21, 9896-9903.
38. Rea, K., Ford, G.K., Olango, W.M., Harhen, B., Roche, M., Finn, D.P., (2014). Mircoinjection of 2-arachidonoyl glycerol into the rat ventral hippocampus differentially modulates contextually induced fear, depending on a persistent pain state. Eur J Neurosci 39, 435-443.
39. Rea, K., Olango, W.M., Harhen, B., Kerr, D.M., Galligan, R., Fitzgerald, S., Moore, M., Roche, M., Finn, D.P., (2013). Evidence for a role of GABAergic and glutamatergic signalling in the basolateral amygdala in endocannabinoid-mediated fear-conditioned analgesia in rats. Pain 154, 576-585.
40. Rizvi, T.A., Ennis, M., Behbehani, M.M., Shipley, M.T., (1991). Connections between the central nucleus of the amygdala and the midbrain periaqueductal gray: Topography and reciprocity. J Comp Neurol 303, 121-131.
41. Robbins, T.W., (2000). Chemical neuromodulation of frontal-executive functions in humans and other animals. Exp Brain Res 133, 130-138.
42. Shih, Y.Y., Chen, Y.Y., Chen, C.C., Chen, J.C., Chang, C., Jaw, F.S., (2008). Whole-brain functional magnetic resonance imaging mapping of acute nociceptive responses induced by formalin in rats using atlas registration-based event-related analysis. J Neurosci Res 86, 1801-1811.
43. Solowij, N., Michie, P.T., Fox, A.M., (1995). Differential impairments of selective attention due to frequency and duration of cannabis use. Biol Psychiatry 37, 731-739.
44. Strangman, N.M., Patrick, S.L., Hohmann, A.G., Tsou, K., Walker, J.M., (1998). Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity. Brain Res 813, 323-328.
45. Thierry, A.M., Gioanni, Y., Degenetais, E., Glowinski, J., (2000). Hippocampo-prefrontal cortex pathway: Anatomical and electrophysiological characteristics. Hippocampus 10, 411-419.
46. van Groen, T., Wyss, J.M., (1990). Extrinsic projections from area CA1 of the rat hippocampus: Olfactory, cortical, subcortical, and bilateral hippocampal formation projections. J Comp Neurol 302, 515-528.
47. Valet, M., Sprenger, T., Boecker, H., Willoch, F., Rummeny, E., Conrad, B., Erhard, P., Tolle, T.R., (2004). Distraction modulates connectivity of the cingulo-frontal cortex and the midbrain during pain-An fMRI analysis. Pain 109, 399-408.
48. Verrico, C.D., Jentsch, J.D., Roth, R.H., Taylor, J.R., (2004). Repeated, intermittent delta(9)-tetrahydrocannabinol administration to rats impairs acquisition and performance of a test of visuospatial divided attention. Neuropsychopharmacology 29, 522-529.
49. Vertes, R.P., (2006). Interactions among the medial prefrontal cortex, hippocampus and midline thalamus in emotional and cognitive processing in the rat. Neuroscience 142, 1-20.
50. Villemure, C., Bushnell, M.C., (2009). Cognitive modulation of pain: How do attention and emotion influence pain processing? Pain 95, 195-199.
51. Wismeijer, A.A., Vingerhoets, A.J., (2005). The use of virtual reality and audiovisual eyeglass systems as adjunct analgesic techniques: A review of the literature. Ann Behav Med 30, 268-278.
52. Wismeijer, A.A., Vingerhoets, A.J., (2005). The use of virtual reality and audiovisual eyeglass systems as adjunct analgesic techniques: A review of the literature. Ann Behav Med 30, 268-278.